M A Cunningham1, T Ono, T D Hewitson
1Department of Medicine, Monash University, Monash Medical Center, Clayton, Australia. malcolmc@its-mmcc1.cc.monash.edu.au
Tissue factor pathway inhibitor (TFPI) is expressed late in crescent formation in human kidney disease. This late TFPI expression correlates with reduced fibrin deposition, suggesting a role in chronic crescentic glomerulonephritis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: